A sight on the current nanoparticle-based gene delivery vectors

Nanoscale Research Letters

Volumn 9, Issue 1, 2014, Pages 1-9

  Dizaj, Solmaz Maleki ^a,b   Jafari, Samira ^a,b   Khosroushahi, Ahmad Yari ^b,c  

^a TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Gene delivery; Inorganic vectors; Nanoparticles; Non viral vectors

Indexed keywords

EFFICIENCY; GENE TRANSFER; MOLECULAR BIOLOGY; NANOPARTICLES; TISSUE; VECTORS;

GENE DELIVERY; GENE DELIVERY VECTORS; INORGANIC PROPERTIES; LOW CYTOTOXICITIES; NONVIRAL VECTORS; TRANSFECTION EFFICIENCY; TRANSFORMATION EFFICIENCY; VIVO TRANSFORMATIONS;

GENES;

EID: 84903986902     PISSN: 19317573     EISSN: 1556276X     Source Type: Journal    
DOI: 10.1186/1556-276X-9-252     Document Type: Review

References (73)

1. Rapti K, Chaanine AH, Hajjar RJ: Targeted gene therapy for the treatment of heart failure. Can J Cardiol 2011, 27(3): 265-283.
2. Pouton CW, Seymour LW: Key issues in non-viral gene delivery. Adv Drug Deliv Rev 2001, 46(1-3): 187-203.
3. Robbins PD, Ghivizzani SC: Viral vectors for gene therapy. Pharmacol Ther 1998, 80(1): 35-47.
4. Wang T, Upponi JR, Torchilin VP: Design of multifunctional non-viral gene vectors to overcome physiological barriers: dilemmas and strategies. Int J Pharm 2012, 427(1): 3-20.
5. Hendriks WT, Ruitenberg MJ, Blits B, Boer GJ, Verhaagen J: Viral vector-mediated gene transfer of neurotrophins to promote regeneration of the injured spinal cord. Prog Brain Res 2004, 146: 451-476.
6. Ponder KP: Vectors in gene therapy. In An Introduction to Molecular Medicine and Gene Therapy. Edited by: Kresina TF. New York: Wiley; 2002: 77-112.
7. Philippi C, Loretz B, Schaefer UF, Lehr CM: Telomerase as an emerging target to fight cancer-opportunities and challenges for nanomedicine. J Control Release 2010, 146(2): 228-240.
8. Higashi T, Khalil IA, Maiti KK, Lee WS, Akita H, Harashima H, Chung SK: Novel lipidated sorbitol-based molecular transporters for non-viral gene delivery. J Control Release 2009, 136(2): 140-147.
9. Kostarelos K, Miller AD: Synthetic, self-assembly ABCD nanoparticles; a structural paradigm for viable synthetic non-viral vectors. Chem Soc Rev 2005, 34(11): 970-994.
10. Mastrobattista E, van der Aa MA, Hennink WE, Crommelin DJ: Artificial viruses: a nanotechnological approach to gene delivery. Nat Rev Drug Discov 2006, 5(2): 115-121.
11. Lu Y: Transcriptionally regulated, prostate-targeted gene therapy for prostate cancer. Adv Drug Deliv Rev 2009, 61(7-8): 572-588.
12. Bharali DJ, Klejbor I, Stachowiak EK, Dutta P, Roy I, Kaur N, Bergey EJ, Prasad PN, Stachowiak MK: Organically modified silica nanoparticles: a nonviral vector forin vivogene delivery and expression in the brain. Proc Natl Acad Sci U S A 2005, 102(32): 11539-11544.
13. Conwell CC, Huang L: Recent advances in non-viral gene delivery. Adv Genet 2005, 53: 1-18.
14. Niidome T, Huang L: Gene therapy progress and prospects: nonviral vectors. Gene Ther 2002, 9(24): 1647-1652.
15. Bigger BW, Tolmachov O, Collombet JM, Fragkos M, Palaszewski I, Coutelle C: An araC-controlled bacterial cre expression system to produce DNA minicircle vectors for nuclear and mitochondrial gene therapy. J Biol Chem 2001, 276(25): 23018-23027.
16. Mayrhofer P, Schleef M, Jechlinger W: Use of minicircle plasmids for gene therapy. Methods Mol Biol 2009, 542: 87-104.
17. Deelman L, Sharma K: Mechanisms of kidney fibrosis and the role of antifibrotic therapies. Curr Opin Nephrol Hypertens 2009, 18(1): 85-90.
18. Lee JM, Yoon TJ, Cho YS: Recent developments in nanoparticle-based siRNA delivery for cancer therapy. Biomed Res Int 2013, 782041(10): 17.
19. Dobson J: Gene therapy progress and prospects: magnetic nanoparticle-based gene delivery. Gene Ther 2006, 13(4): 283-287.
20. Liu C, Zhang N: Chapter 13 - nanoparticles in gene therapy: principles, prospects, and challenges. Prog Mol Biol Transl Sci 2011, 104: 509-562.
21. Sinha R, Kim GJ, Nie S, Shin DM: Nanotechnology in cancer therapeutics: bioconjugated nanoparticles for drug delivery. Mol Cancer Ther 2006, 5(8): 1909-1917.
22. Morachis JM, Mahmoud EA, Sankaranarayanan J, Almutairi A: Triggered rapid degradation of nanoparticles for gene delivery. J Drug Deliv 2012, 2012: 1-7.
23. Panyam J, Labhasetwar V: Biodegradable nanoparticles for drug and gene delivery to cells and tissue. Adv Drug Deliv Rev 2003, 55(3): 329-347.
24. Danhier F, Ansorena E, Silva JM, Coco R, Le Breton A, Preat V: PLGA-based nanoparticles: an overview of biomedical applications. J Control Release 2012, 161(2): 505-522.
25. Nitta SK, Numata K: Biopolymer-based nanoparticles for drug/gene delivery and tissue engineering. Int J Mol Sci 2013, 14(1): 1629-1654.
26. Zhang S, Zhao B, Jiang H, Wang B, Ma B: Cationic lipids and polymers mediated vectors for delivery of siRNA. J Control Release 2007, 123(1): 1-10.
27. Rudolph C, Schillinger U, Ortiz A, Tabatt K, Plank C, Muller RH, Rosenecker J: Application of novel solid lipid nanoparticle (SLN)-gene vector formulations based on a dimeric HIV-1 TAT-peptide in vitro and in vivo. Pharm Res 2004, 21(9): 1662-1669.
28. Bruniaux J, Sulpice E, Mittler F, Texier I, Gidrol X, Navarro F: Cationic lipid nanoemulsions for RNAi screening. In Proceedings of the Technical Proceedings of the 2013 NSTI Nanotechnology Conference and Expo, NSTI-Nanotech. Washington, DC United States; 2013. 12-16 May 2013, vol 3, pp. 323-326.
29. Fishbein I, Chorny M, Levy RJ: Site-specific gene therapy for cardiovascular disease. Curr Opin Drug Discov Devel 2010, 13(2): 203-213.
30. Khan R, Khan MH: Use of collagen as a biomaterial: an update. J Indian Soc Periodontol 2013, 17(4): 539.
31. Karimi M, Avci P, Mobasseri R, Hamblin M, Naderi-Manesh H: The novel albumin-chitosan core-shell nanoparticles for gene delivery: preparation, optimization and cell uptake investigation. J Nanopart Res 2013, 15(5): 1-14.
32. Shi Q, Tiera MJ, Zhang X, Dai K, Benderdour M, Fernandes JC: Chitosan-DNA/siRNA nanoparticles for gene therapy. Non-Viral Gene Ther 2011, 19: 455-480.
33. Raftery R, O'Brien FJ, Cryan SA: Chitosan for gene delivery and orthopedic tissue engineering applications. Molecules (Basel, Switzerland) 2013, 18(5): 5611-5647.
34. Strand SP, Lelu S, Reitan NK, de Lange DC, Artursson P, Vårum KM: Molecular design of chitosan gene delivery systems with an optimized balance between polyplex stability and polyplex unpacking. Biomaterials 2010, 31(5): 975-987.
35. Mamo T, Moseman EA, Kolishetti N, Salvador-Morales C, Shi J, Kuritzkes DR, Langer R, von Andrian U, Farokhzad OC: Emerging nanotechnology approaches for HIV/AIDS treatment and prevention. Nanomedicine 2010, 5(2): 269-285.
36. Thomas M, Lu JJ, Zhang C, Chen J, Klibanov AM: Identification of novel superior polycationic vectors for gene delivery by high-throughput synthesis and screening of a combinatorial library. Pharm Res 2007, 24(8): 1564-1571.
37. Patnaik S, Gupta KC: Novel polyethylenimine-derived nanoparticles for in vivo gene delivery. Expert Opin Drug Deliv 2013, 10(2): 215-228.
38. Morille M, Passirani C, Vonarbourg A, Clavreul A, Benoit J-P: Progress in developing cationic vectors for non-viral systemic gene therapy against cancer. Biomaterials 2008, 29(24-25): 3477-3496.
39. Gillies ER, Frechet JM: Dendrimers and dendritic polymers in drug delivery. Drug Discov Today 2005, 10: 35-43.
40. Lakshminarayanan A, Ravi VK, Tatineni R, Rajesh YB, Maingi V, Vasu KS, Madhusudhan N, Maiti PK, Sood AK, Das S, Jayaraman N: Efficient dendrimer-DNA complexation and gene delivery vector properties of nitrogen-core poly(propyl ether imine) dendrimer in mammalian cells. Bioconjug Chem 2013, 24(9): 1612-1623.
41. Liang GF, Zhu YL, Sun B, Hu FH, Tian T, Li SC, Xiao ZD: PLGA-based gene delivering nanoparticle enhance suppression effect of miRNA in HePG2 cells. Nanoscale Res Lett 2011, 6(447): 6-447.
42. Kabanov AV, Kabanov VA: DNA complexes with polycations for the delivery of genetic material into cells. Bioconjug Chem 1995, 6(1): 7-20.
43. Sun X, Zhang N: Cationic polymer optimization for efficient gene delivery. Mini Rev Med Chem 2010, 10(2): 108-125.
44. Xu W, Ling P, Zhang T: Polymeric micelles, a promising drug delivery system to enhance bioavailability of poorly water-soluble drugs. J Drug Deliv 2013, 2013: 1-15.
45. Dufresne M-H, Gauthier MA, Leroux J-C: Thiol-functionalized polymeric micelles: from molecular recognition to improved mucoadhesion. Bioconjug Chem 2005, 16(4): 1027-1033.
46. Harris TJ, Green JJ, Fung PW, Langer R, Anderson DG, Bhatia SN: Tissue-specific gene delivery via nanoparticle coating. Biomaterials 2010, 31(5): 998-1006.
47. Lian J, Xin Z, Ming L, Yan D, Nongyue H: Current progress in gene delivery technology based on chemical methods and nano-carriers. Theranostics 2014, 4(3): 240-255.
48. Ramos-Perez V, Cifuentes A, Coronas N, Pablo A, Borrós S: Modification of carbon nanotubes for gene delivery vectors: nanomaterial interfaces in biology. Methods Mol Biol 2013, 1025: 261-268.
49. Shi Kam NW, Jessop TC, Wender PA, Dai H: Nanotube molecular transporters: internalization of carbon nanotube-protein conjugates into mammalian cells. J Am Chem Soc 2004, 126(22): 6850-6851.
50. Katragadda CS, Choudhury PK, Murthy P: Nanoparticles as non-viral gene delivery vectors. Indian J Pharm Educ Res 2010, 44(2): 109-111.
51. Isobe H, Nakanishi W, Tomita N, Jinno S, Okayama H, Nakamura E: Gene delivery by aminofullerenes: structural requirements for efficient transfection. Chem An Asian J 2006, 1(1-2): 167-175.
52. Huang F-W, Wang H-Y, Li C, Wang H-F, Sun Y-X, Feng J, Zhang X-Z, Zhuo R-X: PEGylated PEI-based biodegradable polymers as non-viral gene vectors. Acta Biomater 2010, 6(11): 4285-4295.
53. Tang Z, Zhou Y, Sun H, Li D, Zhou S: Biodegradable magnetic calcium phosphate nanoformulation for cancer therapy. Eur J Pharm Biopharm 2014, 2014.
54. Tiwari PK, Soo Lee Y: Gene delivery in conjunction with gold nanoparticle and tumor treating electric field. J Appl Phys 2013, 114(5): 5.
55. Colvin VL, Goldstein AN, Alivisatos AP: Semiconductor nanocrystals covalently bound to metal surfaces with self-assembled monolayers. J Am Chem Soc 1992, 114: 5221-5230.
56. Lu AH, Salabas EL, Schuth F: Magnetic nanoparticles: synthesis, protection, functionalization, and application. Angew Chem Int Ed Engl 2007, 46(8): 1222-1244.
57. Olton DYE, Close JM, Sfeir CS, Kumta PN: Intracellular trafficking pathways involved in the gene transfer of nano-structured calcium phosphate-DNA particles. Biomaterials 2011, 32(30): 7662-7670.
58. Khosravi-Darani K, Mozafari MR, Rashidi L, Mohammadi M: Calcium based non-viral gene delivery: an overview of methodology and applications. Acta Medica Iranica 2010, 48(3): 133-141.
59. Maitra A: Calcium phosphate nanoparticles: second-generation nonviral vectors in gene therapy. Expert Rev Mol Diagn 2005, 5(6): 893-905.
60. Roy I, Mitra S, Mitra A, Mozumdar S: Calcium phosphate nanoparticles as novel non-viral vectors for targeted gene delivery. Int J Pharm 2003, 250: 25-33.
61. Chernousova S, Klesing J, Soklakova N, Epple M: A genetically active nano-calcium phosphate paste for bone substitution, encoding the formation of BMP-7 and VEGF-A. RSC Advances 2013, 3(28): 11155-11161.
62. Sang Jun S, Xia B, Sang Bok L: Inorganic hollow nanoparticles and nanotubes in nanomedicine, Part 1 Drug/gene delivery applications. Drug Discov Today 2007, 12(15/16): 650-656.
63. Kneuer C, Sameti M, Bakowsky U, Schiestel T, Schirra H, Schmidt H, Lehr C-M: A nonviral DNA delivery system based on surface modified silica-nanoparticles can efficiently transfect cells in vitro. Bioconjug Chem 2000, 11(6): 926-932.
64. Du X, Shi B, Liang J, Bi J, Dai S, Qiao SZ: Developing functionalized dendrimer-like silica nanoparticles with hierarchical pores as advanced delivery nanocarriers. Adv Mater 2013, 25(41): 5981-5985.
65. Rzigalinski BA, Strobl JS: Cadmium-containing nanoparticles: perspectives on pharmacology and toxicology of quantum dots. Toxicol Appl Pharmacol 2009, 238(3): 280-288.
66. Biju V, Mundayoor S, Omkumar RV, Anas A, Ishikawa M: Bioconjugated quantum dots for cancer research: present status, prospects and remaining issues. Biotechnol Adv 2010, 27: 27.
67. Probst CE, Zrazhevskiy P, Bagalkot V, Gao X: Quantum dots as a platform for nanoparticle drug delivery vehicle design. Adv Drug Deliv Rev 2013, 65(5): 703-718.
68. Nguyen J, Reul R, Betz T, Dayyoub E, Schmehl T, Gessler T, Bakowsky U, Seeger W, Kissel T: Nanocomposites of lung surfactant and biodegradable cationic nanoparticles improve transfection efficiency to lung cells. J Control Release 2009, 140(1): 47-54.
69. Dames P, Gleich B, Flemmer A, Hajek K, Seidl N, Wiekhorst F, Eberbeck D, Bittmann I, Bergemann C, Weyh T, Trahms L, Rosenecker J, Rudolph C: Targeted delivery of magnetic aerosol droplets to the lung. Nat Nanotechnol 2007, 2(8): 495-499. doi: 10. 1038/nnano. 2007. 217.
70. Thomas R, Park I-K, Jeong Y: Magnetic iron oxide nanoparticles for multimodal imaging and therapy of cancer. Int J Mol Sci 2013, 14(8): 15910-15930.
71. Xu ZP, Zeng QH, Lu GQ, Yu AB: Inorganic nanoparticles as carriers for efficient cellular delivery. Chem Eng Sci 2006, 61(3): 1027-1040.
72. Shyh-Dar L, Song L, Leaf H: Lipoplex and LPD nanoparticles for in vivo gene delivery. Cold Spring Harb Protoc 2006, 2006: 1.
73. Qu X, Li P, Liu D, Liu C, Zhang N: Enhanced gene transfer with multilayered polyplexes assembled with layer-by-layer technique. IET Nanobiotechnol 2012, 6(3): 122-128.